Document Detail

Effects of reserpine on the content and uptake of dopamine and noradrenaline in rabbit arteries.
MedLine Citation:
PMID:  8485926     Owner:  NLM     Status:  MEDLINE    
1. Change with time of the content and uptake of dopamine (DA) and noradrenaline (NA) in the renal, superior mesenteric and femoral arteries and abdominal aorta of rabbit after reserpine administration was examined. Endogenous DA and NA were measured by high performance liquid chromatography coupled with electrochemical detector. 2. A single dose of reserpine (3 mg/kg, i.p.) maximally depleted the endogenous DA and NA contents in the four blood vessels 24 h after the administration; the ratios of reductions were 70-90% and approximately 90% of the normal levels, respectively. The DA contents in all four vessels recovered to the normal level within 4 days after reserpine. However, NA content did not recover to the normal levels within 30 days after reserpine except in the mesenteric artery. 3. The activity of dopamine beta-hydroxylase (DBH) significantly increased in all four blood vessels 1 h after reserpine. Although the DBH activity returned to the normal level after 3 days in the mesenteric artery, it returned within 24 h in the other three vessels. 4. [3H]-Dopamine and [3H]-NA uptake were almost completely depressed 1 h after reserpine. The [3H]-NA uptake in four vessels recovered to the normal level 2-14 days after reserpine, and [3H]-DA uptake recovered after 30-45 days. Thus, the endogenous DA content in blood vessels was completely restored although DA uptake and NA content were still affected. 5. These results suggested that the recovery of stored DA after reserpine was faster than that of stored NA and the recovery of DA uptake after reserpine was slower than NA uptake.(ABSTRACT TRUNCATED AT 250 WORDS)
K Okada; K Shinozuka; K Shimoura; Y Kobayashi; K Hattori; A Nakase
Related Documents :
1407706 - Mesolimbic dopamine release elicited by activation of the accessory olfactory system: a...
9160246 - Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat...
9339816 - Relationships between pb-induced changes in neurotransmitter system function and behavi...
238856 - The effect of penfluridol and some psychotropic drugs on monoamine metabolism in centra...
11758826 - Role of cyclooxygenase-2 in gastric mucosal defense.
7688536 - Copper deficient rat heart can compensate for doxorubicin-induced oxidant stress.
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  20     ISSN:  0305-1870     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-06-07     Completed Date:  1993-06-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  261-7     Citation Subset:  IM    
Department of Pharmacology, Shimane Medical University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arteries / drug effects,  metabolism
Chromatography, High Pressure Liquid
Dopamine / metabolism*
Muscle, Smooth, Vascular / drug effects,  metabolism*
Norepinephrine / metabolism*
Receptors, Dopamine / drug effects,  metabolism
Reserpine / pharmacology*
Reg. No./Substance:
0/Receptors, Dopamine; 50-55-5/Reserpine; 51-41-2/Norepinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Angiotensin converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing co...
Next Document:  Oxygen-haemoglobin dissociation curve in hypoxic rats of first or second generation.